Eris Lifesciences Board Meeting on 20/05/2026 to Consider Dividend

Eris Lifesciences Ltd has scheduled a Board of Directors meeting on May 20, 2026, to consider and approve the standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026. The board will also consider the declaration of an interim dividend for the financial year 2026-27. The trading window is closed from April 1, 2026, and will remain closed until 48 hours after the declaration of the financial results.